title: Perspectives on verteporfin therapy combined with intravitreal corticosteroids.
authors.affiliation: Department of Ophthalmology, University of Vienna, Vienna, Austria. ursula.schmidt-erfurth@meduniwien.ac.at
authors.forename: Ursula
authors.initials: U
authors.lastname: Schmidt-Erfurth
authors.forename: Stephan
authors.initials: S
authors.lastname: Michels
authors.forename: Albert
authors.initials: A
authors.lastname: Augustin
mesh_terms: D020256:Choroidal Neovascularization / Q000188:drug therapy; D003131:Combined Modality Therapy; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D008268:Macular Degeneration / Q000188:drug therapy; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*; D000077362:Verteporfin; D014822:Vitreous Body
chemical_list: D005938:Glucocorticoids; D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin; D014222:Triamcinolone Acetonide